Arrhythmogenic right ventricular cardiomyopathy is a rare inherited heart muscle condition that most often involves the right ventricle, which is the heart chamber responsible for pumping blood to the lungs. Individuals with ARVC may have symptoms of palpitations or fainting due to irregular heart rhythms (arrhythmias). Symptoms may also include shortness of breath due to reduced pumping function of the heart.
Medical Services related to Francis Dominic Pagani MD
The normal aortic valve has three leaflets that open and close to control the flow of blood into the aorta from the left ventricle of the heart as it beats. In contrast, a bicuspid aortic valve, or BAV, has only two leaflets. With this malformation, the valve doesn’t function perfectly, however, it may function adequately for years with no symptoms or obvious signs of a problem. Depending on the degree of malformation, blood flowing through the valve may make an abnormal sound, or a murmur. While some bicuspid aortic valves are silent, the detection of a murmur may be the first indication of bicuspid aortic valve disease.
The top-ranked hospital in Michigan for heart and heart surgery programs, the University of Michigan Cardiovascular Center performs more than 2,000 heart operations annually, sees approximately 3,500 outpatients each year, and delivers a team of experts to make our patients' hospital stay both comfortable and successful.
Dilated cardiomyopathy, or DCM, is a heart muscle condition characterized by gradual weakening of the heart muscle. While DCM may be caused by other conditions, including myocardial infarction, many cases are now known to be caused by genetic mutations carried in families. Individuals with DCM may be only mildly affected or may be severely affected, even in the same family.
The University of Michigan offers the state's only accredited heart failure disease management program, with medical and surgical care, heart-assisting technology and comprehensive rehabilitation programs.
Heart transplant is one of a number of options for severe heart disease. It's not for everyone, and should not be considered unless all other viable treatment options have been unsuccessful. At the University of Michigan Heart Transplant Program, our closely integrated team of cardiac transplant surgeons and transplant cardiologists are able to treat and implant donor hearts in the sickest of patients because of our high volume, vast experience and active research program.
Heart transplant is one of a number of options for severe heart disease and should only be considered when other viable treatment options have been unsuccessful. Since 1984, doctors at the University of Michigan Heart Transplant program have performed approximately 800 heart transplants.
Hypertrophic cardiomyopathy (HCM) is a common genetic cardiac disorder affecting 1 in 500 people. It affects both men and women of all ages, and is characterized by abnormal thickening of the heart muscle.
VADs (ventricular assist devices) are mechanical devices that help your heart pump blood to the rest of your body when other methods don't relieve heart failure symptoms. LVADs, the most common type of VAD, are used to support the left side of the heart, but RVADs may be used to support the right side of the heart as well. The University of Michigan Frankel Cardiovascular Center is home to one of the largest VAD programs in the country, and is one of only a few institutions worldwide that has access to many investigational and FDA-approved mechanical circulatory support devices.
The VAD Program at the University of Michigan offers one of the nation's most comprehensive programs in the area of treatment for severe chronic or acute heart failure. This goes beyond conventional treatment, giving patients access to a broad variety of state-of-the-art options of circulatory support devices and skilled post-implantation care.